BIOMAT Database Logo BIOMAT Database Logo

[Effect of treatment of arterial hypertension on renal function in patients with imminent and overt diabetic nephropathy]. 1994

S Czekalski, and S Pynka, and L Majkowska, and E Andrysiak-Mamos, and B Krzyzanowska-Swiniarska
Klinika Endokrynologii, Nadciśnienia Tetniczego i Chorób Przemiany Materii Pomorskiej Akademii Medycznej w Szczecinie.

The effect was studied of blood pressure lowering treatment on renal failure and albuminuria (UAE) in patients with type I diabetes (IDDM) and imminent nephropathy as well as in patients with over diabetic nephropathy. The group of 24 patients with imminent nephropathy was subdivided: 1. twelve patients with borderline or overt hypertension with mean BP lowered not below 100 mmHg, and 2. twelve patients with BP within the normal limits, taking no hypotensive agents. In the other group of 12 patients with overt diabetic nephropathy hypertension was lowered below 105 mmHg and kept so for at least two years. All patients estimated their glycemia and glycosuria by themselves, ate 0.8 g protein/kg/24 h and about 100 mmol Na/24h. Under hospital conditions the following were estimated: albuminuria, glomerular filtration rate (51Cr EDTA) and effective renal blood flow (131I hippurate). The same examinations were repeated 1 year and 2 years later. The lowering of BP below 100 mmHg in patients with imminent diabetic nephropathy significantly lowered microalbuminuria without changing GFR, ERPF despite good or satisfactory compensation of diabetes. Maintaining BP below 105 mmHg for 2 years did not prevent the patients with overt nephropathy to develop progressive renal failure despite the rate of GFR deterioration and of the increase of albuminuria slowed down.

UI MeSH Term Description Entries
D006977 Hypertension, Renal Persistent high BLOOD PRESSURE due to KIDNEY DISEASES, such as those involving the renal parenchyma, the renal vasculature, or tumors that secrete RENIN. Hypertensions, Renal,Renal Hypertension,Renal Hypertensions
D007676 Kidney Failure, Chronic The end-stage of CHRONIC RENAL INSUFFICIENCY. It is characterized by the severe irreversible kidney damage (as measured by the level of PROTEINURIA) and the reduction in GLOMERULAR FILTRATION RATE to less than 15 ml per min (Kidney Foundation: Kidney Disease Outcome Quality Initiative, 2002). These patients generally require HEMODIALYSIS or KIDNEY TRANSPLANTATION. ESRD,End-Stage Renal Disease,Renal Disease, End-Stage,Renal Failure, Chronic,Renal Failure, End-Stage,Chronic Kidney Failure,End-Stage Kidney Disease,Chronic Renal Failure,Disease, End-Stage Kidney,Disease, End-Stage Renal,End Stage Kidney Disease,End Stage Renal Disease,End-Stage Renal Failure,Kidney Disease, End-Stage,Renal Disease, End Stage,Renal Failure, End Stage
D008297 Male Males
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D003922 Diabetes Mellitus, Type 1 A subtype of DIABETES MELLITUS that is characterized by INSULIN deficiency. It is manifested by the sudden onset of severe HYPERGLYCEMIA, rapid progression to DIABETIC KETOACIDOSIS, and DEATH unless treated with insulin. The disease may occur at any age, but is most common in childhood or adolescence. Diabetes Mellitus, Brittle,Diabetes Mellitus, Insulin-Dependent,Diabetes Mellitus, Juvenile-Onset,Diabetes Mellitus, Ketosis-Prone,Diabetes Mellitus, Sudden-Onset,Diabetes, Autoimmune,IDDM,Autoimmune Diabetes,Diabetes Mellitus, Insulin-Dependent, 1,Diabetes Mellitus, Type I,Insulin-Dependent Diabetes Mellitus 1,Juvenile-Onset Diabetes,Type 1 Diabetes,Type 1 Diabetes Mellitus,Brittle Diabetes Mellitus,Diabetes Mellitus, Insulin Dependent,Diabetes Mellitus, Juvenile Onset,Diabetes Mellitus, Ketosis Prone,Diabetes Mellitus, Sudden Onset,Diabetes, Juvenile-Onset,Diabetes, Type 1,Insulin Dependent Diabetes Mellitus 1,Insulin-Dependent Diabetes Mellitus,Juvenile Onset Diabetes,Juvenile-Onset Diabetes Mellitus,Ketosis-Prone Diabetes Mellitus,Sudden-Onset Diabetes Mellitus
D003928 Diabetic Nephropathies KIDNEY injuries associated with diabetes mellitus and affecting KIDNEY GLOMERULUS; ARTERIOLES; KIDNEY TUBULES; and the interstitium. Clinical signs include persistent PROTEINURIA, from microalbuminuria progressing to ALBUMINURIA of greater than 300 mg/24 h, leading to reduced GLOMERULAR FILTRATION RATE and END-STAGE RENAL DISEASE. Diabetic Glomerulosclerosis,Glomerulosclerosis, Diabetic,Diabetic Kidney Disease,Diabetic Nephropathy,Intracapillary Glomerulosclerosis,Kimmelstiel-Wilson Disease,Kimmelstiel-Wilson Syndrome,Nodular Glomerulosclerosis,Diabetic Kidney Diseases,Glomerulosclerosis, Nodular,Kidney Disease, Diabetic,Kidney Diseases, Diabetic,Kimmelstiel Wilson Disease,Kimmelstiel Wilson Syndrome,Nephropathies, Diabetic,Nephropathy, Diabetic,Syndrome, Kimmelstiel-Wilson
D005260 Female Females
D005919 Glomerular Filtration Rate The volume of water filtered out of plasma through glomerular capillary walls into Bowman's capsules per unit of time. It is considered to be equivalent to INULIN clearance. Filtration Rate, Glomerular,Filtration Rates, Glomerular,Glomerular Filtration Rates,Rate, Glomerular Filtration,Rates, Glomerular Filtration
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000328 Adult A person having attained full growth or maturity. Adults are of 19 through 44 years of age. For a person between 19 and 24 years of age, YOUNG ADULT is available. Adults

Related Publications

S Czekalski, and S Pynka, and L Majkowska, and E Andrysiak-Mamos, and B Krzyzanowska-Swiniarska
Effect of thiazolidinedione treatment on proteinuria and renal hemodynamic in type 2 diabetic patients with overt nephropathy.
November 2012, Hormone and metabolic research = Hormon- und Stoffwechselforschung = Hormones et metabolisme,
S Czekalski, and S Pynka, and L Majkowska, and E Andrysiak-Mamos, and B Krzyzanowska-Swiniarska
[Effect of treatment with labetalol on renal function in arterial hypertension secondary to parenchymal nephropathy and in essential arterial hypertension].
November 1980, Recenti progressi in medicina,
S Czekalski, and S Pynka, and L Majkowska, and E Andrysiak-Mamos, and B Krzyzanowska-Swiniarska
Effects of ACE inhibitors on renal function in incipient and overt diabetic nephropathy.
January 1996, Journal of diabetes and its complications,
S Czekalski, and S Pynka, and L Majkowska, and E Andrysiak-Mamos, and B Krzyzanowska-Swiniarska
Diabetic nephropathy and arterial hypertension. The effect of antihypertensive treatment.
May 1983, Diabetes,
S Czekalski, and S Pynka, and L Majkowska, and E Andrysiak-Mamos, and B Krzyzanowska-Swiniarska
Treating hypertension in the patient with overt diabetic nephropathy.
March 2007, Seminars in nephrology,
S Czekalski, and S Pynka, and L Majkowska, and E Andrysiak-Mamos, and B Krzyzanowska-Swiniarska
Blood pressure changes and renal function in incipient and overt diabetic nephropathy.
January 1985, Hypertension (Dallas, Tex. : 1979),
S Czekalski, and S Pynka, and L Majkowska, and E Andrysiak-Mamos, and B Krzyzanowska-Swiniarska
Monitoring kidney function in type 2 diabetic patients with incipient and overt diabetic nephropathy.
May 2006, Diabetes care,
S Czekalski, and S Pynka, and L Majkowska, and E Andrysiak-Mamos, and B Krzyzanowska-Swiniarska
Effect of urokinase on preservation of renal function in patients with diabetic nephropathy.
January 1991, The Journal of diabetic complications,
S Czekalski, and S Pynka, and L Majkowska, and E Andrysiak-Mamos, and B Krzyzanowska-Swiniarska
Effects of a vegetarian, supplemented diet on renal function, proteinuria, and glucose metabolism in patients with 'overt' diabetic nephropathy and renal insufficiency.
January 1988, Contributions to nephrology,
S Czekalski, and S Pynka, and L Majkowska, and E Andrysiak-Mamos, and B Krzyzanowska-Swiniarska
White coat hypertension in NIDDM patients with and without incipient and overt diabetic nephropathy.
May 1997, Diabetes care,
Copied contents to your clipboard!